politics

Galderma Reports Increased Demand for Treatments Amid Rising GLP-1 Use

23 Temmuz 2026CNBC

Galderma, the maker of Botox, is experiencing an early boost in demand due to the rising popularity of GLP-1 medications, which are associated with weight loss. This trend has led to an increase in cases of facial volume loss, commonly referred to as 'Ozempic face.' The company anticipates that this growing interest…
GLP-1 medications, initially developed for diabetes management, have gained traction for their weight loss benefits. As their use increases, so does the awareness of side effects such as facial volume loss, prompting consumers to seek aesthetic solutions.
The phenomenon of 'Ozempic face' highlights a unique intersection between medical advancements and aesthetic concerns. As more individuals turn to GLP-1 medications for weight management, the resulting side effects may create new markets for cosmetic treatments.

NewsAI özeti

This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional for personalized guidance.

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.